These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 833274)

  • 1. Gastric emptying and secretion in Zollinger-Ellison syndrome.
    Dubois A; Eerdewegh PV; Gardner JD
    J Clin Invest; 1977 Feb; 59(2):255-63. PubMed ID: 833274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.
    Sarosiek J; Jensen RT; Maton PN; Peura DA; Harlow D; Feng T; McCallum RW; Pisegna JR
    Am J Gastroenterol; 2000 May; 95(5):1158-65. PubMed ID: 10811321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperacidity and hypersecretion of the stomach stump--a possibility of Zollinger-Ellison syndrome].
    Lityński M; Altman W
    Pol Tyg Lek; 1968 Oct; 23(44):1698-700. PubMed ID: 5701469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gastric secretion in Zollinger-Ellison syndrome].
    Konturek S; Biernat J; Konturek D
    Pol Tyg Lek; 1972 Sep; 27(36):1385-7. PubMed ID: 5078725
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of vagotomy in Zollinger-Ellison syndrome.
    Richardson CT; Feldman M; McClelland RN; Dickerman RM; Kumpuris D; Fordtran JS
    Gastroenterology; 1979 Oct; 77(4 Pt 1):682-6. PubMed ID: 467924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exploration of the gastric acid secretion in man. Methods and results].
    Lambert R; Granthil C; Minaire Y
    Lyon Med; 1972 Mar; 227(6):545-52. PubMed ID: 5053997
    [No Abstract]   [Full Text] [Related]  

  • 7. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.
    Raufman JP; Collins SM; Pandol SJ; Korman LY; Collen MJ; Cornelius MJ; Feld MK; McCarthy DM; Gardner JD; Jensen RT
    Gastroenterology; 1983 Jan; 84(1):108-13. PubMed ID: 6128284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of depot somatostatin on gastrin and stomach secretion in normal subjects and in patients with Zollinger-Ellison syndrome].
    Raptis S; Dollinger HC; Escobar-Jimenez F; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():1006-9. PubMed ID: 1029163
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic function in patients with the Zollinger-Ellison syndrome. Observations concerning acid-bicarbonate secretion ratios.
    Dreiling DA; Greenstein A
    Med Chir Dig; 1972; 1(1):1-4. PubMed ID: 5054001
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
    Lamers CB; Festen HP; van Tongeren JH
    Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dose-response curves obtained with metiamide in the Zollinger-Ellison syndrome].
    Mignon M; Galmiche JP; Bonfils S
    Biol Gastroenterol (Paris); 1975; 8(3):239-44. PubMed ID: 764881
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metiamide treatment in five patients with Zollinger-Ellison syndrome.
    Bonfils S; Bernier JJ; Mignon M; Lambert R; Bernades P; L'Hirondel C; Accary JP; Kloeti G
    Digestion; 1977; 15(1):43-52. PubMed ID: 838177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical recovery owing to target parietal cell failure in a patient with Zollinger-Ellison syndrome.
    Wiersinga WM; Tytgat GN
    Gastroenterology; 1977 Dec; 73(6):1413-7. PubMed ID: 199524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric secretion in duodenal ulcer, with particular reference to the diagnosis of Zollinger-Ellison syndrome.
    Kaye MD; Rhodes J; Beck P
    Gastroenterology; 1970 Apr; 58(4):476-81. PubMed ID: 4314536
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of gastric acid secretion by metiamide in Zollinger-Ellison syndrome.
    Mainardi M; Maxwell V; Sturdevant RA; Isenberg JI
    Am J Dig Dis; 1975 Mar; 20(3):280-1. PubMed ID: 1124750
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastric cycle nucleotide concentration in health and disease. Response to secretagogues and role of circulating gastrin and intragastric acid secretion.
    Levine RA; Schwartzel EH; Bachman S; Talev JN
    Gastroenterology; 1977 Oct; 73(4 Pt 1):737-45. PubMed ID: 196973
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stimulation of gastric secretion after calcium infusion in the Zollinger-Ellison syndrome].
    Basso N; Passaro E; Lezoche E; Mennini G; Speranza V
    J Chir (Paris); 1972; 103(5):493-8. PubMed ID: 4653425
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
    Ippoliti AF; Isenberg JI; Hagie L
    Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
    Morocutti A; Merrouche M; Bjaaland T; Humphries T; Mignon M
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1439-44. PubMed ID: 17081164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.